Prof. Ahmed El-Kased, President of Menoufia University, witnessed the signing ceremony of a cooperation protocol between the National Liver Institute and the University Cancer Institute. The protocol was signed by Prof. Osama Hegazy, Dean of the National Liver Institute, and Prof. Hossam El-Fol, Dean of the Cancer Institute. The ceremony was attended by the University's Vice Presidents, Prof. Sobhi Sharaf for Community Service and Environmental Development and Prof. Nasser Abdel-Bari for Education and Students, Prof. Ekramy Gamal, Secretary General of the University, and Dr. Mohamed El-Senbawy, Executive Director of the Cancer Institute.

The University President praised the strategic cooperation between the Oncology Institute and the Liver Institute, which represents a pioneering model of medical and research integration that contributes to enhancing the quality of healthcare for patients. He emphasized the importance of integration between medical specialties to achieve significant progress in the fields of diagnosis, treatment, and scientific research, as well as the formation of multidisciplinary treatment teams and the adoption of standardized protocols for diagnosis and treatment. This helps the Oncology Institute provide advanced technologies for diagnosing cancer in its early stages, increases the effectiveness of treatment, improves the chances of recovery, and contributes to the development of new treatments and a deeper understanding of the causes and prevention of cancer.

The University President emphasized that the University Oncology Institute represents a scientific and humanitarian beacon of light, combining advanced treatment, scientific research, and awareness with the goal of reducing the burden of disease and improving treatment outcomes. The presence of such an institute within the university system enhances the university's role not only in education, but also in serving the community and combating one of the most dangerous modern diseases. Therefore, the University is paying great attention to completing all the equipment for the institute and providing it with all necessary support to enable it to become an integrated treatment center and a platform for scientific research and community awareness, as well as to train medical personnel specialized in the field of oncology.

Prof. Hossam El-Fol, Dean of the Cancer Institute, added that this protocol is part of a series of cooperation agreements concluded with various specialized medical centers and institutes concerned with the diagnosis and treatment of tumors. This comes within the framework of completing all the institute's equipment and its strategic plan to improve specialized healthcare and develop scientific research in the field of oncology. This will make the University's Cancer Institute a vital medical and scientific edifice in the fight against cancer, which represents one of the most serious health challenges of the modern era. The role of the institute is not only an integrated treatment center, but also a platform for scientific research, as it includes specialized departments: pediatric oncology and hematology, oncology surgery, radiation oncology and nuclear medicine, oncology and hematology, oncology biology, medical statistics and cancer epidemiology, and the palliative medicine department. The institute also awards master's degrees in the following specialties: oncology and hematology, radiation oncology and nuclear medicine, epidemiology and control of cancer, pediatric oncology and hematology, and palliative medicine, and doctoral degrees in the following specialties: oncology surgery, oncology and hematology, radiation oncology, oncology biology, epidemiology and control of cancer, and nuclear medicine. Dr. Osama Hegazy, Dean of the Liver Institute, expressed his happiness with this fruitful and constructive cooperation. This cooperation aims to improve the quality of medical care provided to cancer patients, exchange expertise to discover the latest methods for diagnosing and treating liver tumors, manage the side effects of chemotherapy on liver patients, promote resident physician exchange programs between the two institutes, and utilize laboratories and the latest diagnostic, therapeutic, and radiology equipment to provide accurate diagnosis and advanced treatment for cancer using the latest technologies (such as targeted radiotherapy, immunotherapy, and microsurgery). Furthermore, it aims to provide customized treatment programs for each patient according to the latest international protocols.